🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Germ cell tumors, a relatively rare disease, but most common malignancy in ...
Status
Unknown
Location
Chemotherapy Unit, Dept of Urology, Instituite of Oncology
Start Date
2008-09
Trial ID
NCT00772694
Treatments Being Tested
The purpose of this study is to test the effectiveness of DermiPsor's DPS-1...
Status
Suspended
Location
Boston VA Hospital
Start Date
2013-04
Trial ID
NCT01368887
Treatments Being Tested
This will be a 2-week oral dose study of PF 04991532, performed in patients...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-12
Trial ID
NCT01469065
Treatments Being Tested
This is a phase 1b, open-Label study of sorafenib with BIIB022 in subjects ...
Status
Completed
Location
Resesarch Site
Start Date
2009-08
Trial ID
NCT00956436
MNA-3521-011 study is a multi-centre, open-label, first-in-human, phase 1a/...
Status
Unknown
Location
National University Hospital
Start Date
2016-03-01
Trial ID
NCT02716012
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-05-25
Trial ID
NCT03563170
Sorafenib is the standard therapy for hepatocellular carcinoma (HCC) with e...
Status
Unknown
Location
Korea University Ansan Hospital
Start Date
2012-03-01
Trial ID
NCT03518502
Treatments Being Tested
This study is a trial of dexanabinol in patients with advanced tumours. The...
Status
Unknown
Location
University Hospital Bonn, Study Center Bonn (SZB) Clinical Study Core Unit Institute of Clinical Chemistry and Clinical Pharmacology University Hospital Bonn, Sigmund-Freud-Str. 25
Start Date
2015-04
Trial ID
NCT02423239
Treatments Being Tested
This study will evaluate the safety and tolerability of R1507 in combinatio...
Status
Terminated
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00811993
The main purpose of this study is to evaluate the safety and effectiveness ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2014-08-08
Trial ID
NCT02178358